USPTO serial 78937975
AVIMER
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PAPPAS, MATTHEW
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AVIMER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mountain View, CA
Mountain View, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark I. Feldman, Christina L. Martini
Mark I. Feldman, Christina L. Martini DLA Piper LLP (US)P.O. Box 64807Chicago, IL 60664-0807UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Recombinant peptides with high avidity for binding with particular protein targets for the purpose of treating mammalian diseases, namely, inflammatory, immunological, rheumatological, neurological, oncological, hematological, urological, nephrological, metabolic, endocrinological, pulmonary, cardiovascular, musculoskeletal, infectious, ophthalmological, otolaryngological, neoplastic, autoimmune and renal diseases, for use in the treatment of loss of bone mass, chronic anemia, hyperparathyroidism, hypercalcemia, bone metabolism related diseases and disorders, human immune diseases and conditions, viral infections, injury to epithelial cells and tissues, obesity, diabetes, hypertension, dyslipidemia, infertility, surgical or soft tissue damage and injury to epithelial cells and tissues, for use in stimulating production of red blood cells, white blood cells, platelets and platelet precursor cells, for modulating calcium, phosphorous, or parathyroid hormone levels in the blood, and for use in anticancer and antiviral applications, modulating weight loss, regulating reproductive function, promoting wound healing, preventing the loss of bone mass, restoring the level of white blood cells, promoting growth and differentiation of neurons and preventing neuronal death | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 23, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 23, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 3, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 2, 2011 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 29, 2011 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 29, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 15, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 13, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 13, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 27, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 26, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 20, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 20, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 4, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 21, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 21, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 15, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 15, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 22, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 22, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 23, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 30, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 26, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 21, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 12, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 11, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 11, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 11, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 4, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 19, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 14, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 11, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 11, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 11, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 9, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 28, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2006 | NWAP | NEW APPLICATION ENTERED | — |